Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review

Overview of attention for article published in Journal of the Egyptian National Cancer Institute, August 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 47 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 4,221 followers.

RT @renesugar: Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review #MECFS #LongCovid…

17 Apr 2024

Reply Repost Favourite

Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review #MECFS #LongCovid #ritonavir #HSP90 https://t.co/c2niZP7G8A https://t.co/kUjUJBUhX3

17 Apr 2024

Reply Repost Favourite

https://t.co/c2niZP78j2 Brexpiprazole "has both blocking as well as the stimulating activity as it acts as a partial agonist of 5-HT1A and D2 receptors besides acting as an antagonist of norepinephrine alpha 1B/2C and 5-HT2A receptors"

21 Dec 2022

Reply Repost Favourite

Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review #LongCovid #NeuroCovid https://t.co/c2niZP78j2

21 Dec 2022

Reply Repost Favourite